The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 26, 2019
Filed:
Nov. 07, 2016
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Michael T. Rudd, Collegeville, PA (US);
Edward J. Brnardic, Lansdale, PA (US);
Yuntae Kim, Yongin-Si, KR;
Robert S. Meissner, Newton, MA (US);
Vanessa L. Rada, Hatfield, PA (US);
Shawn J. Stachel, Perkasie, PA (US);
Celina V. Zerbinatti, Hamburg, DE;
Michael T. Rudd, Collegeville, PA (US);
Edward J. Brnardic, Lansdale, PA (US);
Yuntae Kim, Yongin-Si, KR;
Robert S. Meissner, Newton, MA (US);
Vanessa L. Rada, Hatfield, PA (US);
Shawn J. Stachel, Perkasie, PA (US);
Celina V. Zerbinatti, Hamburg, DE;
Abstract
In its many embodiments, the present invention provides substituted cyanopyridine containing compounds of the Formula (I): and acceptable salts thereof, wherein R, R, R, R, R, X, Y, Q, and the moiety are as defined herein. The novel compounds of the invention, and pharmaceutically acceptable compositions comprising a compound thereof, are useful as Liver X-β receptor (LXRβ) agonists, and may be useful for treating or preventing pathologies related thereto. Such pathologies include, but are not limited to, inflammatory diseases and diseases characterized by defects in cholesterol and lipid metabolism, such as Alzheimer's disease.